Haemonetics Corp (HAE)

EBITDA Growth

-20.29%

Quarterly · Period ending:

HAE logo

HAE EBITDA Growth

Year-over-year change vs the same period a year earlier

Latest reported-20.29%
HAE Quarterly EBITDA YoY % (-80.15% → -20.29%)
High-resolution chart · PNG

HAE ebitda growth history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Haemonetics Corp EBITDA Growth — Quarterly
Period endingEBITDA Growth
127.789%
186.6764%
18.8881%
-11.6025%
-9.9686%
-1.288%
-0.6944%
-6.3953%
28.2258%
-52.2901%
-1.3699%
13.9073%
-16.7785%
103.1008%
0.6897%
-9.0361%
-14.3678%
-5.8394%
-19.8895%
-7.2626%
-1.6949%
-13.8365%
8.3832%
2.8736%
8.589%
-1.8519%
1.8293%
8.0745%
18.1159%
20.8955%
20.5882%
28.8%
25.4545%
27.619%
41.6667%
40.4494%
41.0256%
-73.3503%
-75.5725%
-77.3537%
-80.1527%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.